[HTML] sciencedirect.com

[HTML][HTML] JAK inhibition as a new treatment strategy for patients with COVID-19

J Huang, C Zhou, J Deng, J Zhou - Biochemical Pharmacology, 2022 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic continues to
spread globally. The rapid dispersion of coronavirus disease 2019 (COVID-19) caused by …
被引用次数：16 相关文章

JAK inhibition as a new treatment strategy for patients with COVID-19.

J Huang, C Zhou, J Deng, J Zhou - Biochemical Pharmacology, 2022 - europepmc.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic continues to
spread globally. The rapid dispersion of coronavirus disease 2019 (COVID-19) caused by …
[HTML] nih.gov

[HTML][HTML] JAK inhibition as a new treatment strategy for patients with COVID-19

J Huang, C Zhou, J Deng, J Zhou - Biochemical Pharmacology, 2022 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic continues to
spread globally. The rapid dispersion of coronavirus disease 2019 (COVID-19) caused by …

JAK inhibition as a new treatment strategy for patients with COVID-19.

J Huang, C Zhou, J Deng, J Zhou - 2022 - cabidigitallibrary.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic continues to
spread globally. The rapid dispersion of coronavirus disease 2019 (COVID-19) caused by …

JAK inhibition as a new treatment strategy for patients with COVID-19

J Huang, C Zhou, J Deng… - Biochemical …, 2022 - pubmed.ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic continues to
spread globally. The rapid dispersion of coronavirus disease 2019 (COVID-19) caused by …